Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects
Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
devdiscourse1h
Key Developments in Health: Novo Nordisk's Wegovy, Zevra's Breakthrough, and More
This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...
devdiscourse17h
Breaking Health News: Major Drug Approvals and Controversies
The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...
Pharmabiz21h
EMA committee recommends Novo Nordisk’s Wegovy label update to reflect reduced heart failure symptoms and improved physical function
Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...
TAG24 NEWS on MSN6h
The winding, fitful path to the wildly popular weight loss drug Ozempic
Together with Habener and others, she proved this theory through lab experiments and human trials, identifying its ...
WUWM5h
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
News Medical46m
Lipid biomarkers in children with obesity linked to future cardiometabolic risks
Scientists from the University of Copenhagen have detected lipid biomarkers in children and teenagers with obesity that indicate an increased risk of developing type 2 diabetes, liver and heart ...
Investor's Business Daily on MSN17h
Netflix, Eli Lilly Lead 5 Fast Growers Near Buy Points
Netflix and Eli Lilly lead this weekend's list of five stocks near buy points that are all enjoying rapid sales growth.